ADC Therapeutics SA (ADCT) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
ADC Therapeutics SA (ADCT) Bundle
Simplify ADC Therapeutics SA (ADCT) valuation with this customizable DCF Calculator! Featuring real ADC Therapeutics SA (ADCT) financials and adjustable forecast inputs, you can test scenarios and uncover ADC Therapeutics SA (ADCT) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3 | .0 | 33.9 | 209.9 | 69.6 | 57.9 | 48.2 | 40.2 | 33.5 | 27.9 |
| Revenue Growth, % | 0 | -100 | 0 | 518.89 | -66.86 | -16.72 | -16.72 | -16.72 | -16.72 | -16.72 |
| EBITDA | -114.1 | -219.3 | -223.7 | -108.1 | -146.8 | -29.1 | -24.3 | -20.2 | -16.8 | -14.0 |
| EBITDA, % | -4876.07 | 100 | -659.6 | -51.48 | -210.99 | -50.3 | -50.3 | -50.3 | -50.3 | -50.3 |
| Depreciation | 1.6 | 2.0 | 2.6 | 2.4 | 3.3 | 21.3 | 17.7 | 14.8 | 12.3 | 10.3 |
| Depreciation, % | 70.34 | 100 | 7.75 | 1.14 | 4.7 | 36.79 | 36.79 | 36.79 | 36.79 | 36.79 |
| EBIT | -115.7 | -221.2 | -226.3 | -110.4 | -150.0 | -29.3 | -24.4 | -20.3 | -16.9 | -14.1 |
| EBIT, % | -4946.41 | 100 | -667.35 | -52.61 | -215.69 | -50.52 | -50.52 | -50.52 | -50.52 | -50.52 |
| Total Cash | 115.6 | 439.2 | 466.5 | 326.4 | 278.6 | 57.9 | 48.2 | 40.2 | 33.5 | 27.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | 30.2 | 73.0 | 25.2 | 30.1 | 25.1 | 20.9 | 17.4 | 14.5 |
| Account Receivables, % | 0 | 100 | 89.09 | 34.76 | 36.2 | 52.01 | 52.01 | 52.01 | 52.01 | 52.01 |
| Inventories | 2.5 | 6.5 | 11.1 | 18.6 | 16.2 | 30.7 | 25.6 | 21.3 | 17.7 | 14.8 |
| Inventories, % | 105.64 | 100 | 32.79 | 8.84 | 23.26 | 52.98 | 52.98 | 52.98 | 52.98 | 52.98 |
| Accounts Payable | 3.3 | 5.3 | 12.1 | 12.4 | 15.6 | 30.6 | 25.5 | 21.2 | 17.7 | 14.7 |
| Accounts Payable, % | 142.26 | 100 | 35.62 | 5.88 | 22.38 | 52.78 | 52.78 | 52.78 | 52.78 | 52.78 |
| Capital Expenditure | -2.1 | -2.8 | -6.4 | -2.3 | -3.2 | -13.5 | -11.2 | -9.3 | -7.8 | -6.5 |
| Capital Expenditure, % | -91.79 | 100 | -18.8 | -1.09 | -4.62 | -23.26 | -23.26 | -23.26 | -23.26 | -23.26 |
| Tax Rate, % | -22.84 | -22.84 | -22.84 | -22.84 | -22.84 | -22.84 | -22.84 | -22.84 | -22.84 | -22.84 |
| EBITAT | -116.3 | -221.5 | -207.0 | -111.3 | -184.3 | -28.8 | -24.0 | -20.0 | -16.6 | -13.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -116.0 | -224.4 | -238.8 | -161.1 | -130.9 | -25.4 | -12.4 | -10.3 | -8.6 | -7.2 |
| WACC, % | 22.82 | 22.82 | 21.46 | 22.82 | 22.82 | 22.55 | 22.55 | 22.55 | 22.55 | 22.55 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -41.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -7 | |||||||||
| Terminal Value | -35 | |||||||||
| Present Terminal Value | -13 | |||||||||
| Enterprise Value | -54 | |||||||||
| Net Debt | -154 | |||||||||
| Equity Value | 100 | |||||||||
| Diluted Shares Outstanding, MM | 82 | |||||||||
| Equity Value Per Share | 1.23 |
What You Will Receive
- Comprehensive Financial Model: ADC Therapeutics' actual data facilitates accurate DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential drivers.
- Real-Time Calculations: Instant updates ensure you view results as you implement changes.
- Professional-Grade Template: A polished Excel file crafted for top-tier valuation.
- Adaptable and Reusable: Designed for versatility, allowing for repeated use in detailed forecasting.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for ADC Therapeutics SA (ADCT).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to the biotech sector.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit ADC Therapeutics SA (ADCT).
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to ADC Therapeutics SA (ADCT).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for streamlined analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based ADCT DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates ADC Therapeutics' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial evaluation.
Why Choose This Calculator for ADC Therapeutics (ADCT)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your analytical needs.
- Real-Time Feedback: Observe immediate changes in ADC Therapeutics’ valuation as you modify inputs.
- Preconfigured Data: Comes with ADC Therapeutics’ latest financial information for expedited analysis.
- Endorsed by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing ADC Therapeutics (ADCT) investments.
- Biotech Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in ADC Therapeutics (ADCT) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to biotech.
- Pharmaceutical Enthusiasts: Gain insights into how biotech companies like ADC Therapeutics (ADCT) are valued in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations for ADC Therapeutics SA (ADCT).
- Real-World Data: ADC Therapeutics' historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Full annual and quarterly breakdowns for deeper insights into ADC Therapeutics SA (ADCT).
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to ADC Therapeutics SA (ADCT).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to ADC Therapeutics SA (ADCT).